San Diego, California (PRWEB) May 14, 2012
Nicholas J. Drakulich, the Founding Partner of THE DRAKULICH FIRM, APLC, has been named to the Plaintiffs' Steering Committee in the Actos (Pioglitazone) Products Liability Litigation (MDL 2299) currently underway in U.S. District Court for the Western District of Louisiana. Mr. Drakulich was appointed by the Honorable Rebecca F. Doherty in an order dated April 13, 2012. Lawsuits pending in the litigation allege that patients who ingested Actos for more than a year are at increased risks for developing bladder cancer. Plaintiffs further allege that Takeda Pharmaceuticals and other Defendants promoted Actos as a safe and effective treatment for Type II diabetes, even though they knew or should have known that taking Actos for longer than 12 months increased the risk of bladder cancer and had other serious side effects.
"I’m honored to have been selected as a member of the Actos PSC and to represent people who allege to have been seriously harmed by this medication," Nicholas (“Nick”) Drakulich said. The team of Actos litigation attorneys will work to prove that the Defendants failed to adequately warn people of the full spectrum of the drug’s side effects, including bladder cancer.
About THE DRAKULICH FIRM, APLC
THE DRAKULICH FIRM, APLC is an established law firm that provides experienced and passionate representation across a range of civil litigation matters, including products liability. For a number of years the firm has devoted a substantial portion of its practice to pharmaceutical and medical device litigation. With offices in California and Nevada, the firm represents clients throughout California, Nevada, and beyond.
Firm principal Nicholas J. Drakulich has consistently received an AV rating from Martindale-Hubbell, the highest possible rating indicating preeminent legal ability and the utmost ethical standards. Mr. Drakulich has also been selected as a member of the National Trial Lawyers and the Multi-Million Dollar Advocates Forum. THE DRAKULICH FIRM, APLC is recognized in The Bar Register of Preeminent Lawyers and is a member of the International Society of Primerus Law Firms.